𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neoadjuvant therapy with Docetaxel (TAX) and Cisplatin (CIS) in patients (pts) with non-small cell lung cancer (NSCLC), stage IIIA, N2 is highly active with few toxicities

✍ Scribed by Betticher, D.C; Hsu Schmitz, S.-F; Gauthier, Y; von Briel, C; Roth, A; Spiliopoulos, A; Pless, M; Stahel, R; Weder, W; Tötsch, M; Cerny, T; Ris, H.B


Book ID
118569870
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
118 KB
Volume
29
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES